Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0076 | 1 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.00087 | 1 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.0047 | 1 |